Literature DB >> 7332589

Characterization of the exometabolite of Leishmania donovani as a novel glycopeptidophosphosphingolipid.

L H Semprevivo, M E MacLeod.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7332589     DOI: 10.1016/0006-291x(81)90247-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  7 in total

1.  The association of distinct acid phosphatases with the flagella pocket and surface membrane fractions obtained from bloodstream forms of Trypanosoma rhodesiense.

Authors:  J McLaughlin
Journal:  Mol Cell Biochem       Date:  1986-05       Impact factor: 3.396

2.  Identification and characterization of a major surface antigen of Giardia lamblia.

Authors:  D A Einfeld; H H Stibbs
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

3.  The effect of tunicamycin on Leishmania brasiliensis. Glycosylation and the cell surface components.

Authors:  A Hernandez; A Misle; J Urdaneta; F Dagger
Journal:  Mol Biol Rep       Date:  1987       Impact factor: 2.316

4.  Evidence for lipid-protein interactions in the attachment of antigens to a low-density membrane fraction isolated from Trypanosoma rhodesiense.

Authors:  J McLaughlin
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

5.  Biochemical and immunological characterization of exometabolites from an Indian strain of Leishmania donovani promastigotes grown in a chemically defined medium.

Authors:  K Kar; K Mukerji; S Kar; D Sarkar; A Bhattacharya; D K Ghosh
Journal:  Mol Cell Biochem       Date:  1991-12-11       Impact factor: 3.396

6.  Phenotypic diversity of cloned lines of Leishmania major promastigotes.

Authors:  C L Greenblatt; E Handman; G F Mitchell; F L Battye; L F Schnur; D Snary
Journal:  Z Parasitenkd       Date:  1985

7.  An amphipathic sulphated glycoconjugate of Leishmania: characterization with monoclonal antibodies.

Authors:  E Handman; C L Greenblatt; J W Goding
Journal:  EMBO J       Date:  1984-10       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.